Skip to content

APOTHEEK BUYCK

Active Private limited companyfounded 1982active for 43 yearsDrapstraat 70, 9810 Nazareth-De PinteKBO/BCE: BE 0423.325.222 subsidiary of

Lifetime

25 annual accounts with figures on one time axis, 43 filings since 1983
peak of €277,187 in 2024
€223,030▼ 19.5%
lowest -€51,561 in 2009
€46,778▼ 21.1%
peak of €371,696 in 2025
€371,696▲ 14.4%
€703,168▲ 31.5%
peak of 2.2 FTE in 2022
1.6 FTE▼ 11.1%
Board1 name since 2009
1 director
Owners
99.87%
Documentsfilings and deeds
12-07-202619 days before the deadline
2025abbreviated format
Gross margin from €277,187 to €223,030Staff from 1.8 FTE to 1.6 FTEEquity from €324,918 to €371,696Debts from €534,632 to €703,168Investments €204,752Cash from €25,699 to €42,900

Key points

from the 2025 annual accounts

Equity

€371,696 ▲ 14.4%

APOTHEEK BUYCK has made a profit without a break since 2010.

Investments

€204,676 3.3 times depreciation
20212022202320242025

Green is investment, beige is depreciation. Machinery stands 897.1% higher than in 2024.

Filings

43 annual accounts since 1983
AprilJune31 JulyOctober199520102025

The last five annual accounts were filed 19 to 34 days before the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 17,054 companies had the same profile as APOTHEEK BUYCK has now. Each dot stands for 43 companies, two years later.

94.3%
were still trading
5.0%
stopped another way
0.6%
went bankrupt
  • Micro
  • 20 years or older
  • solvency 30% or more
  • a profit under 5% of the balance sheet

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 498,062 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 17,054 companies, not a prediction for APOTHEEK BUYCK. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Manager,
  • 99.87%score equity €977,054 (2025) · annual accounts 30-09-2025 of
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0423325222
changes role from manager to director acts as permanent representative · “Het geven van seminaries, opleidingen en presentaties. Het schrijven, verzorgen, begeleiden en uitgeven van…” (deed in Dutch) · General meeting of 12-12-2023 · Gazette deed
Environmental permit granted Outbuildings, Convert or extend · decided by Nazareth-De Pinte
Environmental permit refused Outbuildings, Convert or extend · decided by Nazareth-De Pinte
All 58 events

Comparable companies

same main activity, similar in size and age
Company
APOTHEEK BUYCK Nazareth-De Pinte €1.1m €223,030 34.6% 1.6
Apotheek PENNE KATRIEN Ninove €1.0m €214,727 54.8% 1.7
APOTHEEK BRUGGEMAN Ghent €1.2m €209,652 41.0% 1.3
Van der Vennet Apotheek Ghent €1.1m €261,213 29.2% 1.5
Apotheek Obus – Oudegem Dendermonde €1.1m €181,021 20.7% 2
APOTHEEK VELGHE Maarkedal €1.1m €189,820 12.5% 1.7
APOTHEEK DEMEYERE Kruisem €1.4m €225,907 72.4% 1.4

These companies have the same main activity as APOTHEEK BUYCK: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €1m and €1.4m, founded between 1980 and 1991.

Official details

Source: KBO
Status
Active since 20-12-1982Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Joint committee
313Pharmacies and pricing offices · annual accounts 2025
Establishment unit
2.021.439.4189810 Nazareth-De Pinte, since 01-01-1983
Financial year end
31 December
Peppol
Reachable since 10-12-2025
Company details

Annual accounts 2025

≈ €1.0mestimated
€1.1m▲ 25.0%
Employeeson 31-12-2025
2=
Filing
Filed on 12-07-2026, 19 days before the end of the filing period
Financials

Insights on APOTHEEK BUYCK

APOTHEEK BUYCK files the abbreviated format. That format states no turnover. The gross margin rose from €176,806 in 2001 to €223,030 in 2025.

The balance sheet grew most in 2009 through fixed assets, financed with long-term debt.

holds all the shares.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about APOTHEEK BUYCK

What is the company number of APOTHEEK BUYCK?
The company number of APOTHEEK BUYCK is 0423.325.222. The VAT number is the same number with BE in front: BE 0423.325.222.
Where is APOTHEEK BUYCK based?
The registered office is at Drapstraat 70, 9810 Nazareth-De Pinte.Company details
What does APOTHEEK BUYCK do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of APOTHEEK BUYCK?
APOTHEEK BUYCK is a private limited company (BV).
When was APOTHEEK BUYCK founded?
APOTHEEK BUYCK was founded on 20-12-1982.
Is APOTHEEK BUYCK still active?
Yes, APOTHEEK BUYCK is an active enterprise in the KBO register.
How many employees does APOTHEEK BUYCK have?
APOTHEEK BUYCK had an average of 1.6 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does APOTHEEK BUYCK fall under?
In its 2025 annual accounts, APOTHEEK BUYCK states joint committee 313 (Pharmacies and pricing offices).
What is the turnover of APOTHEEK BUYCK?
The turnover in financial year 2025 is about €1.0m. This figure is estimated from the gross margin of €223,030 and 43 comparable companies (NACE 477). It probably lies between €690,000 and €2.2m.
Is APOTHEEK BUYCK profitable?
In financial year 2025, APOTHEEK BUYCK made a profit of €46,778.
Where can I find the annual accounts of APOTHEEK BUYCK?
APOTHEEK BUYCK filed 43 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of APOTHEEK BUYCK due?
APOTHEEK BUYCK must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.